Travere Therapeutics's total assets for Q4 2025 were $605.19M, an increase of 12.37% from the previous quarter. TVTX total liabilities were $490.36M for the fiscal quarter, a 5.45% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.